Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
EIDD-2801 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/21/2021 3 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 15 8
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
SinaCurcumin® Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021 2 0
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2